473 related articles for article (PubMed ID: 29046485)
1. Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease.
Krishnamoorthy S; Pace B; Gupta D; Sturtevant S; Li B; Makala L; Brittain J; Moore N; Vieira BF; Thullen T; Stone I; Li H; Hobbs WE; Light DR
JCI Insight; 2017 Oct; 2(20):. PubMed ID: 29046485
[TBL] [Abstract][Full Text] [Related]
2. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.
Belcher JD; Chen C; Nguyen J; Zhang P; Abdulla F; Nguyen P; Killeen T; Xu P; O'Sullivan G; Nath KA; Vercellotti GM
Antioxid Redox Signal; 2017 May; 26(14):748-762. PubMed ID: 26914345
[TBL] [Abstract][Full Text] [Related]
3. Bach1 inhibitor HPP-D mediates γ-globin gene activation in sickle erythroid progenitors.
Palani CD; Zhu X; Alagar M; Attucks OC; Pace BS
Blood Cells Mol Dis; 2024 Jan; 104():102792. PubMed ID: 37633023
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons.
Rivers A; Vaitkus K; Jagadeeswaran R; Ruiz MA; Ibanez V; Ciceri F; Cavalcanti F; Molokie RE; Saunthararajah Y; Engel JD; DeSimone J; Lavelle D
Exp Hematol; 2018 Nov; 67():60-64.e2. PubMed ID: 30125603
[TBL] [Abstract][Full Text] [Related]
5. Monomethylfumarate induces γ-globin expression and fetal hemoglobin production in cultured human retinal pigment epithelial (RPE) and erythroid cells, and in intact retina.
Promsote W; Makala L; Li B; Smith SB; Singh N; Ganapathy V; Pace BS; Martin PM
Invest Ophthalmol Vis Sci; 2014 May; 55(8):5382-93. PubMed ID: 24825111
[TBL] [Abstract][Full Text] [Related]
6. Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.
Zhang Y; Paikari A; Sumazin P; Ginter Summarell CC; Crosby JR; Boerwinkle E; Weiss MJ; Sheehan VA
Blood; 2018 Jul; 132(3):321-333. PubMed ID: 29884740
[TBL] [Abstract][Full Text] [Related]
7. Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway.
Macari ER; Lowrey CH
Blood; 2011 Jun; 117(22):5987-97. PubMed ID: 21464371
[TBL] [Abstract][Full Text] [Related]
8. MIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell disease.
Li B; Zhu X; Ward CM; Starlard-Davenport A; Takezaki M; Berry A; Ward A; Wilder C; Neunert C; Kutlar A; Pace BS
Exp Hematol; 2019 Feb; 70():85-96.e5. PubMed ID: 30412705
[TBL] [Abstract][Full Text] [Related]
9. Conjugate prodrug AN-233 induces fetal hemoglobin expression in sickle erythroid progenitors and β-YAC transgenic mice.
Oseghale AR; Zhu X; Li B; Peterson KR; Nudelman A; Rephaeli A; Xu H; Pace BS
Blood Cells Mol Dis; 2019 Nov; 79():102345. PubMed ID: 31351219
[TBL] [Abstract][Full Text] [Related]
10. Tenofovir disoproxil fumarate induces fetal hemoglobin production in K562 cells and β-YAC transgenic mice: A therapeutic approach for γ-globin induction.
Khan F; Ali H; Musharraf SG
Exp Cell Res; 2020 Sep; 394(2):112168. PubMed ID: 32653411
[TBL] [Abstract][Full Text] [Related]
11. Correction of murine sickle cell disease using gamma-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin.
Pestina TI; Hargrove PW; Jay D; Gray JT; Boyd KM; Persons DA
Mol Ther; 2009 Feb; 17(2):245-52. PubMed ID: 19050697
[TBL] [Abstract][Full Text] [Related]
12. Potential role of LSD1 inhibitors in the treatment of sickle cell disease: a review of preclinical animal model data.
Rivers A; Jagadeeswaran R; Lavelle D
Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R840-R847. PubMed ID: 30067082
[TBL] [Abstract][Full Text] [Related]
13. RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model.
Rivers A; Vaitkus K; Ruiz MA; Ibanez V; Jagadeeswaran R; Kouznetsova T; DeSimone J; Lavelle D
Exp Hematol; 2015 Jul; 43(7):546-53.e1-3. PubMed ID: 25931013
[TBL] [Abstract][Full Text] [Related]
14. Cilostazol-mediated reversion of γ-globin silencing is associated with a high level of HbF production: A potential therapeutic candidate for β-globin disorders.
Ali H; Khan F; Musharraf SG
Biomed Pharmacother; 2021 Oct; 142():112058. PubMed ID: 34426256
[TBL] [Abstract][Full Text] [Related]
15. Forced chromatin looping raises fetal hemoglobin in adult sickle cells to higher levels than pharmacologic inducers.
Breda L; Motta I; Lourenco S; Gemmo C; Deng W; Rupon JW; Abdulmalik OY; Manwani D; Blobel GA; Rivella S
Blood; 2016 Aug; 128(8):1139-43. PubMed ID: 27405777
[TBL] [Abstract][Full Text] [Related]
16. Dietary supplementation with sulforaphane attenuates liver damage and heme overload in a sickle cell disease murine model.
Panda H; Keleku-Lukwete N; Kuga A; Fuke N; Suganuma H; Suzuki M; Yamamoto M
Exp Hematol; 2019 Sep; 77():51-60.e1. PubMed ID: 31404577
[TBL] [Abstract][Full Text] [Related]
17. Novel histone deacetylase inhibitor CT-101 induces γ-globin gene expression in sickle erythroid progenitors with targeted epigenetic effects.
Junker LH; Li B; Zhu X; Koti S; Cerbone RE; Hendrick CL; Sangerman J; Perrine S; Pace BS
Blood Cells Mol Dis; 2022 Mar; 93():102626. PubMed ID: 34856533
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsive patients with sickle cell disease in correlation with Index of Hydroxyurea Responsiveness.
Zhu X; Hu T; Ho MH; Wang Y; Yu M; Patel N; Pi W; Choi JH; Xu H; Ganapathy V; Kutlar F; Kutlar A; Tuan D
Haematologica; 2017 Dec; 102(12):1995-2004. PubMed ID: 28971909
[TBL] [Abstract][Full Text] [Related]
19. Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes.
Campbell AD; Cui S; Shi L; Urbonya R; Mathias A; Bradley K; Bonsu KO; Douglas RR; Halford B; Schmidt L; Harro D; Giacherio D; Tanimoto K; Tanabe O; Engel JD
Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18808-13. PubMed ID: 22042865
[TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibition induces both antioxidant and hb f responses in sickle cell disease via the nrf2 pathway.
Pullarkat V; Meng Z; Tahara SM; Johnson CS; Kalra VK
Hemoglobin; 2014; 38(3):188-95. PubMed ID: 24670032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
